Finally, quantitation of the methylation levels in MDA-MB-453 cell line confirmed a hypermethylated phenotype at CDH1 and GSTP1 promoters beside a differential methylation pattern at DNMT3B promoter in breast cancer. This evidence concerns the gene CDH1 and breast carcinoma.